Earlier evidences also show the association between VCAM-1 and diabetic kidney disease and the significant involvement of P-selectin; a marker of platelet activation, which activates procoagulant imbalance in the pathogenesis of diabetic nephropathy among patients with type 2 diabetes mellitus (7, 29, 30). This evidence concerns the gene VCAM1 and type 2 diabetes mellitus.